Coway Announces Financial Results for Q1 FY2026

Coway Announces Financial Results for Q1 FY2026

SEOUL, South Korea, May 8, 2026 /PRNewswire/ -- Coway Co., Ltd., the "Best Life Solution Company," has today reported its financial results for the first quarter of 2026. Coway Financial Results "Driven by strong demand for our leading products and...

Chance Pharma Announces NMPA Acceptance of New Drug Application for Investigational Respiratory Drug CXG87

Chance Pharma Announces NMPA Acceptance of New Drug Application for Investigational Respiratory Drug CXG87

HANGZHOU, China, May 8, 2026 /PRNewswire/ -- Chance Pharmaceuticals ("Chance" or "Chance Pharma"), a clinical-stage biotechnology company dedicated to the research and development of innovative inhalation therapies, today announced that the Center...

Autoliv Announces Results of 2026 Annual Stockholders Meeting

Autoliv Announces Results of 2026 Annual Stockholders Meeting

STOCKHOLM, May 8, 2026 /PRNewswire/ -- Autoliv, Inc., (NYSE: ALV and SSE: ALIV.sdb), the worldwide leader in automotive safety systems, today announced the results of its annual general meeting of stockholders held on May 7, 2026. Annual General...

Grand Park City Hall Announces 2026 Summer Getaway Sale

Grand Park City Hall Announces 2026 Summer Getaway Sale

SINGAPORE, May 7, 2026 /PRNewswire/ -- Grand Park City Hall, a 5-star Modern Heritage hotel strategically located at the intersection of Singapore's heritage landmarks and modern luxury, has launched its 2026 Summer Getaway Sale. This offer allows...

ADGM Announces Man Group's Commitment to Establish Presence in Abu Dhabi

ADGM Announces Man Group's Commitment to Establish Presence in Abu Dhabi

ABU DHABI, UAE, May 7, 2026 /PRNewswire/ -- ADGM, the international financial centre of Abu Dhabi, today announced that Man Group plc, a London-listed alternative investment firm with approximately USD 228.7 billion in total assets under management,...

Acer Announces Q1'26 Net Income at NT$702 Million, Up 36.3% Year-on-Year

Acer Announces Q1'26 Net Income at NT$702 Million, Up 36.3% Year-on-Year

TAIPEI, May 7, 2026 /PRNewswire/ -- Acer Inc. (TWSE: 2353) announced its financial results for the first quarter of 2026. Consolidated revenues reached NT$72.42 billion, up 18.1% year-on-year (YoY); gross profits reached NT$8.09 billion with 24.8%...

Webull HK Announces "True Zero Fees" as Standard Pricing, Becoming Hong Kong's First True $0 Commission & $0 Platform Fees Broker

Webull HK Announces "True Zero Fees" as Standard Pricing, Becoming Hong Kong's First True $0 Commission & $0 Platform Fees Broker

Trading Fee Questionnaire – Redeem Coffee Voucher & Coffee Mug for Free Plus "Smart Strike Carnival" at Causeway Bay Lee Theatre Plaza – Play Games, Check In, Win Prizes Raising Market Awareness of "True Zero Fees" Trading Model HONG KONG, May...

Blaize Announces Pricing of $35 Million Public Offering of Common Stock

Blaize Announces Pricing of $35 Million Public Offering of Common Stock

EL DORADO HILLS, Calif., May 6, 2026 /PRNewswire/ -- Blaize Holdings, Inc. (Nasdaq: BZAI, Nasdaq: BZAIW) ("Blaize," the "Company," "we," "our," or "us"), a leader in programmable, energy-efficient AI computing, announced today the pricing of its...

TETRIS LLC LAND 1 PTY LTD ANNOUNCES OFFERING OF AUD 41,644,550 SENIOR SECURED LOAN NOTE OFFER

TETRIS LLC LAND 1 PTY LTD ANNOUNCES OFFERING OF AUD 41,644,550 SENIOR SECURED LOAN NOTE OFFER

MELBOURNE, Australia, May 6, 2026 /PRNewswire/ -- Tetris LLC Land 1 Pty Ltd ACN 685 914 121 in its own capacity and as trustee of the Tetris LLC Land Trust 1 (the Issuer) is seeking to raise a total of AUD 41,644,550 in funds by the issue of loan...

Alebund Pharmaceuticals Announces Completion of Patient Enrollment in Global Phase III Pivotal Multi-Regional Clinical Trial of AP301 for Hyperphosphatemia

Alebund Pharmaceuticals Announces Completion of Patient Enrollment in Global Phase III Pivotal Multi-Regional Clinical Trial of AP301 for Hyperphosphatemia

SHANGHAI, May 6, 2026 /PRNewswire/ -- Alebund Pharmaceuticals (Jiangsu) Limited ("Alebund" or the "Company"), an integrated biopharmaceutical company focusing on developing innovative therapies for the treatment of renal diseases and related chronic...

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • ...
  • 62
  • menu
    menu